Drug intelligence / Profile preview

acyl ghrelin + desacyl ghrelin

Development stage
Unknown
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Acyl ghrelin + desacyl ghrelin is a combination of the two major circulating isoforms of the peptide hormone ghrelin. Acylated (AG) and desacyl (DAG) forms have distinct biological activities. Acyl ghrelin acts as an agonist at the growth hormone secretagogue receptor (GHSR-1a), stimulating appetite, adiposity, and growth hormone release. Desacyl ghrelin does not bind GHSR-1a but exerts independent effects on metabolism and cell differentiation through other mechanisms or possibly novel receptors. The combination has been shown to modulate insulin sensitivity and glucose metabolism more favorably than acylated form alone in human studies[1][2]. Both forms also promote skeletal muscle differentiation via p38 activation independently of GHSR-1a[4][6]. This combination is under investigation for its potential roles in metabolic disorders, muscle wasting conditions, and cardiovascular diseases.

Other names
acylated ghrelin + des-acyl ghrelinAG + DAGacyl-ghrelin plus des-acyl-ghrelin
02

Targets

UAG-R (Unacylated ghrelin receptor)GHSR (Growth hormone secretagogue receptor)

Beyond the preview

Go deeper on acyl ghrelin + desacyl ghrelin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acyl ghrelin + desacyl ghrelin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call